Story perspectives

Breakthrough Therapies Transform Pediatric Leukemia Treatment Landscape

9/5/2025

40 3

Summary

Story summary

St. Jude Children's Research Hospital advances pediatric leukemia treatment through personalized approaches and genetic research.
University of Oxford's CAR-iNKT therapy outperforms CAR-T therapy in mice for leukemia cell clearance.
CAR-iNKT cells offer off-the-shelf storage, vital for high-risk patients needing urgent care.
Children's Hospital Los Angeles conducts trials on CAR T-cells for acute myeloid leukemia and solid tumors.
Research focuses on improving access to pediatric cancer treatment and enhancing survival rates.

1 of 1

Story summary

St. Jude Children's Research Hospital advances pediatric leukemia treatment through personalized approaches and genetic research.
University of Oxford's CAR-iNKT therapy outperforms CAR-T therapy in mice for leukemia cell clearance.
CAR-iNKT cells offer off-the-shelf storage, vital for high-risk patients needing urgent care.
Children's Hospital Los Angeles conducts trials on CAR T-cells for acute myeloid leukemia and solid tumors.
Research focuses on improving access to pediatric cancer treatment and enhancing survival rates.